Neoantigens in precision cancer immunotherapy: from identification to clinical applications

Immunotherapies targeting cancer neoantigens are safe, effective, and precise. Neoantigens can be identified mainly by genomic techniques such as next-generation sequencing and high-throughput single-cell sequencing; proteomic techniques such as mass spectrometry; and bioinformatics tools based on h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiao, Jia, Qingzhu, Zhang, Jing, Zhu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433083/
https://www.ncbi.nlm.nih.gov/pubmed/35838545
http://dx.doi.org/10.1097/CM9.0000000000002181